via IL-23 RegulationAssociated Increased Mucus - Controls IL-17 Respiratory Virus-Induced TLR7 Activation

The response to respiratory syncytial virus (RSV), negative strand ssRNAvirus, depends upon the ability to recognize specific path-ogen-associated targets. In the current study, the role of TLR7 that recognizes ssRNAwas examined. Using TLR7 2 / 2 mice, we found that the response to RSV infection in the lung was more pathogenic as assessed by significant increases in inflammation and mucus production. Although there appeared to be no effect of TLR7 deficiency on type I IFN, the pathology was associated with an alteration in T cell responses with increases in mucogenic cytokines IL-4, IL-13, and IL-17. Examination of dendritic cells from TLR7 2 / 2 animals indicated a preferential activation of IL-23 (a Th17-promoting cytokine) and a decrease in IL-12 production. Neutralization of IL-17 in the TLR7 2 / 2 mice resulted in a significant decrease in the mucogenic response in the lungs of the RSV-infected mice. Thus, without TLR7-mediated responses, an altered immune environment ensued with a significant effect on airway epithelial cell remodeling and goblet cell hyper/metaplasia, leading to increased mucus production. The Journal of Immunology , 2010, 185: 2231–2239.

[1]  K. Mills,et al.  Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. , 2009, Immunity.

[2]  Qingshan Li,et al.  AP-1 Activated by Toll-like Receptors Regulates Expression of IL-23 p19* , 2009, The Journal of Biological Chemistry.

[3]  J. Crowe,et al.  A Chimeric A2 Strain of Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction , 2009, Journal of Virology.

[4]  H. Jessen,et al.  A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression , 2009, AIDS.

[5]  L. Guillot,et al.  TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model. , 2009, Vaccine.

[6]  L. Anderson,et al.  Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2 , 2008, Journal of Virology.

[7]  O. Ramilo,et al.  MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus , 2008, Proceedings of the National Academy of Sciences.

[8]  M. Schaller,et al.  B Cell Antigen Presentation Promotes Th2 Responses and Immunopathology during Chronic Allergic Lung Disease , 2008, PloS one.

[9]  M. Nyegaard,et al.  Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders , 2008, Thorax.

[10]  E. Hollams,et al.  Presymptomatic differences in Toll-like receptor function in infants who have allergy. , 2008, The Journal of allergy and clinical immunology.

[11]  R. Coffman,et al.  Development of TLR inhibitors for the treatment of autoimmune diseases , 2008, Immunological reviews.

[12]  G. Matlashewski,et al.  Immunization with a Toll-Like Receptor 7 and/or 8 Agonist Vaccine Adjuvant Increases Protective Immunity against Leishmania major in BALB/c Mice , 2008, Infection and Immunity.

[13]  B. Williams,et al.  TLR7 Is Involved in Sequence-Specific Sensing of Single-Stranded RNAs in Human Macrophages1 , 2008, The Journal of Immunology.

[14]  J. Casanova,et al.  Human Toll‐like receptor‐dependent induction of interferons in protective immunity to viruses , 2007, Immunological reviews.

[15]  T. Pollin,et al.  Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children1 , 2007, The Journal of Immunology.

[16]  T. Berg,et al.  Association of TLR7 single nucleotide polymorphisms with chronic HCV‐infection and response to interferon‐a‐based therapy , 2007, Journal of viral hepatitis.

[17]  P. Sly,et al.  TLR4 Polymorphisms Mediate Impaired Responses to Respiratory Syncytial Virus and Lipopolysaccharide1 , 2007, The Journal of Immunology.

[18]  S. Turvey,et al.  Common human Toll-like receptor 4 polymorphisms--role in susceptibility to respiratory syncytial virus infection and functional immunological relevance. , 2007, Clinical immunology.

[19]  A. Hata,et al.  CD14 -550 C/T, which is related to the serum level of soluble CD14, is associated with the development of respiratory syncytial virus bronchiolitis in the Japanese population. , 2007, The Journal of infectious diseases.

[20]  S. Kunkel,et al.  MyD88-Mediated Instructive Signals in Dendritic Cells Regulate Pulmonary Immune Responses during Respiratory Virus Infection1 , 2007, The Journal of Immunology.

[21]  A. Prescott,et al.  Proximal effects of Toll-like receptor activation in dendritic cells. , 2007, Current opinion in immunology.

[22]  A. Heinzmann,et al.  TLR-4 and CD14 Polymorphisms in Respiratory Syncytial Virus Associated Disease , 2007, Disease markers.

[23]  Allan R. Brasier,et al.  Retinoic Acid-Inducible Gene I Mediates Early Antiviral Response and Toll-Like Receptor 3 Expression in Respiratory Syncytial Virus-Infected Airway Epithelial Cells , 2006, Journal of Virology.

[24]  R. Peebles,et al.  Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. , 2006, The American journal of pathology.

[25]  L. Cosmi,et al.  Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release. , 2006, The Journal of allergy and clinical immunology.

[26]  M. Boukhvalova,et al.  Analysis of TLR4 Polymorphic Variants: New Insights into TLR4/MD-2/CD14 Stoichiometry, Structure, and Signaling1 , 2006, The Journal of Immunology.

[27]  Zhengfan Jiang,et al.  Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. , 2006, Annual review of immunology.

[28]  A. Gruber,et al.  Deletion of TLR3 Alters the Pulmonary Immune Environment and Mucus Production during Respiratory Syncytial Virus Infection , 2006, The Journal of Immunology.

[29]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[30]  B. Graham,et al.  Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. , 2005, The Journal of allergy and clinical immunology.

[31]  J. Hiscott,et al.  Gene Expression and Antiviral Activity of Alpha/Beta Interferons and Interleukin-29 in Virus-Infected Human Myeloid Dendritic Cells , 2005, Journal of Virology.

[32]  Christophe Caux,et al.  A type I interferon autocrine–paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells , 2005, The Journal of experimental medicine.

[33]  S. Finke,et al.  Inhibition of Toll-Like Receptor 7- and 9-Mediated Alpha/Beta Interferon Production in Human Plasmacytoid Dendritic Cells by Respiratory Syncytial Virus and Measles Virus , 2005, Journal of Virology.

[34]  C. Duckett,et al.  Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression , 2005, Journal of Virology.

[35]  M. Colonna,et al.  Dendritic cells respond to influenza virus through TLR7‐ and PKR‐independent pathways , 2005, European journal of immunology.

[36]  M. Schaller,et al.  Toll-like receptors as key mediators in innate antifungal immunity. , 2004, Medical mycology.

[37]  N. Amariglio,et al.  Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. , 2004, The Journal of infectious diseases.

[38]  Akiko Iwasaki,et al.  Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Ehl,et al.  The role of Toll‐like receptor 4 versus interleukin‐12 in immunity to respiratory syncytial virus , 2004, European journal of immunology.

[40]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[41]  A. Gagro,et al.  Increased Toll‐like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis , 2004, Clinical and experimental immunology.

[42]  R. Welliver.  Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. , 2003, The Journal of pediatrics.

[43]  Y. Ho,et al.  Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop* , 2003, The Journal of Biological Chemistry.

[44]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[45]  S. Akira,et al.  Recognition of pathogen-associated molecular patterns by TLR family. , 2003, Immunology letters.

[46]  R. Lemanske.  The Childhood Origins of Asthma (COAST) study , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[47]  R. Garofalo,et al.  Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. , 2002, The Journal of infectious diseases.

[48]  N. Sigurs.  A cohort of children hospitalised with acute RSV bronchiolitis: impact on later respiratory disease. , 2002, Paediatric respiratory reviews.

[49]  N. Sigurs.  Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease , 2002, Respiratory research.

[50]  B. Graham,et al.  The Role of IFN in Respiratory Syncytial Virus Pathogenesis , 2002, The Journal of Immunology.

[51]  L. Anderson,et al.  Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus , 2001, Journal of Virology.

[52]  J. Shellito,et al.  Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.

[53]  Douglas T. Golenbock,et al.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.

[54]  L. O’Neill.  The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. , 2000, Biochemical Society transactions.

[55]  D. Sherrill,et al.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years , 1999, The Lancet.

[56]  J. Lötvall,et al.  Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. , 1999, Journal of immunology.

[57]  M. Clare-Salzler,et al.  Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases , 2009 .

[58]  J. Price.  Acute and long-term effects of viral bronchiolitis in infancy , 2007, Lung.

[59]  M. Buc,et al.  Toll-like receptors. I. Structure, function and their ligands. , 2005, Folia biologica.

[60]  Tomoki Ito,et al.  Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9 , 2004, Springer Seminars in Immunopathology.

[61]  J. Lötvall,et al.  Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. , 2000, The Journal of allergy and clinical immunology.

[62]  H. Maassab,et al.  Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine. , 1999, Vaccine.